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ABSTRACT 
 
 
The Golgi plays a central role for post-translational modifications of properly folded 
proteins from the ER (e.g. glycosylation and sulfation) as well as vesicular transport of 
correctly modified proteins to their final destination. When the synthesis of secretory or 
membrane proteins is increased and overwhelms the functional capacity of the Golgi 
apparatus (Golgi stress), eukaryotic cells activate a homeostatic mechanism called the 
Golgi stress response in order to upregulate the capacity of the Golgi. Recent studies 
have revealed five Golgi stress response pathways such as the TFE3, CREB3, HSP47, 
MAPK-ETS and proteoglycan pathways, which regulates the general function of the 
Golgi, apoptosis, cell survival, spliceosome and cell death, and glycosylation of 
proteoglycans, respectively. Here, we have uncovered a novel response pathway, named 
the mucin pathway, that enhances the expression of glycosylation enzymes for mucins 
(such as GALNT5, GALNT8 and GALNT18) to compensate for the insufficiency in 
mucin-type glycosylation in the Golgi (mucin-type Golgi stress). Unexpectedly, we 
found that TFE3, a key transcription factor regulating the TFE3 pathway, was also 
induced and activated upon mucin-type Golgi stress, suggesting that the mucin pathway 
transmits a crosstalk signal to the TFE3 pathway. Promoter analysis of the human TFE3 
gene revealed a novel enhancer element that regulates transcriptional induction of the 
TFE3 gene in response to mucin-type Golgi stress, of which consensus sequence is 
ACTTCC(N9)TCCCCA. We named this sequence the mucin-type Golgi stress response 
element (MGSE). These observations suggested that crosstalk signal from the mucin 
pathway to the TFE3 pathway plays an important role in the regulation of the 
mammalian Golgi stress response.  
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UPRE unfolded protein response element 
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XBP1 X-box binding protein 1 
Y1H Yeast one hybrid screening 
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 CHAPTER ONE 
    INTRODUCTION 
 
 
1.1 Organelle Autoregulation 
 
Eukaryotic cells have various organelles such as the endoplasmic reticulum (ER), Golgi 
apparatus, mitochondria, lysosomes and peroxisomes. The amount of each organelle 
appears to be separately and strictly regulated in accordance with cellular needs by the 
mechanism of organelle autoregulation (Sasaki and Yoshida, 2015). Upon cell division, 
the quantity of each organelle is multiplied accordingly to keep its quantity constant. 
Intriguingly, when cells require more function of a particular organelle due to 
insufficiency of its capacity (organelle stress), cells activate the homeostatic mechanism 
in order to specifically augment the amount of the organelle (Fig. 1). For instance, 
during the differentiation of plasma cells, the ER is expanded to support folding of huge 
amount of secretory and membrane proteins (Wiest et al., 1990). Similarly, during 
differentiation of secretory mucous cells of Brunner’s gland the Golgi apparatus is 
extensively expanded (Fig. 2) (Berger and Roth, 1997). Thus, these suggest that 
organelle autoregulation is an important homeostatic mechanism to adjust the capacity 
of each organelle to the cellular demands.  
Organelle autoregulation is indispensable for eukaryotic cells in order to 
regulate cellular functions, and it is one of the fundamental issues in cell biology. In 
principle, organelle autoregulation consists of four factors: (1) sensors that detect 
insufficiency of organelle function, (2) transcription factors that upregulate the 
expression of genes related to organelle function, (3) enhancer elements to which the 
transcription factors bind, and (4) target genes whose expression is augmented by 
organelle autoregulation, resulting in upregulation of organelle capacity (Fig. 1) (Sasaki 
and Yoshida, 2019). Focusing on the Golgi apparatus, this section will emphasize the 
essentials of the molecular mechanism of the Golgi stress response and its response 
pathways. Nevertheless, it is extremely important to describe about the ER stress 
response since it has been well-characterized in the previous studies and other 
organelles seem to have fundamentals similar to the ER stress response. 
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Fig. 1 The fundamentals of organelle autoregulation 
 
 
Fig. 2. The amount of the Golgi in hepatocytes (a) is almost negligible compared to that in 
Brunner's gland mucous secreting cells (b) (Mol. bio. of the cell, 5th ed., Alberts et al., 2002) 
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1.2 The Endoplasmic Reticulum (ER) Stress Response 
 
There are three distinct, well-conserved pathways in the mammalian ER stress response: 
the ATF6, IRE1 and PERK pathways. The ATF6 pathway regulates expression of ER 
chaperone genes (Okada et al., 2002; Yamamoto et al., 2007), whereas the IRE1 
pathway augments expression of factors for ER-associated degradation (Calfon et al., 
2002; Cox et al., 1993; Mori et al., 1993; Shen et al., 2001; Hiderou Yoshida et al., 
2001; Yoshida et al., 2003). The PERK pathway controls ER stress-induced apoptosis 
(Harding et al., 1999a, 2000; Yan et al., 2002). As mentioned in the concept of 
‘organelle autoregulation’, each pathway regulating the ER stress response has (1) a 
sensor that detects insufficiency of ER function (accumulation of unfolded proteins in 
the ER, which is called ER stress), (2) a transcription factor that binds to an enhancer 
element, (3) a specific enhancer element that lies in the promoter regions of the target 
genes, and (4) target genes of which expression is upregulated to relieve ER stress. In 
the case of the ATF6 pathway, the sensor, the transcription factor, the enhancer element 
and the target genes are pATF6(P), pATF6(N), ERSE and ER chaperone genes, 
respectively (Haze et al., 1999; Hiderou Yoshida et al., 2001; Yoshida et al., 1998, 
2000), and those of the IRE1 pathway are IRE1, pXBP1(S), UPRE and ERAD genes, 
respectively (Calfon et al., 2002; Shen et al., 2001; Yamamoto et al., 2008; Hiderou 
Yoshida et al., 2001; Yoshida et al., 2003). As for the PERK pathway, PERK is the 
sensor, ATF4 is the transcription factor, AARE is the enhancer element and apoptosis-
associated factors are the target genes (Harding et al., 1999b, 2000). The essentials of 
the ER stress response are summarized in Fig. 3 (Taniguchi and Yoshida, 2017).  
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Fig. 3. There are three mammalian ER stress response pathways: the IRE1, PERK and ATF6 
pathways as described in the text. (Taniguchi and Yoshida, 2017) 
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1.3 The Golgi Stress Response and Organelle Zone 
 
The Golgi apparatus is an organelle where posttranslational modification of secretory 
and membrane proteins synthesized in the ER takes place before they are selectively 
transported to their final destination. When large amount of secretory and membrane 
proteins are transported from the ER to the Golgi,  they can overwhelm the functional 
capacity of the Golgi, leading to Golgi stress and activation of the Golgi stress response. 
Compared to the ER stress response, the Golgi stress response has been less studied but 
the principles are still the same. In this section, we will briefly describe the recent works 
of the Golgi stress response and organelle zones that has been proposed residing within 
all organelles including the Golgi.  
 
1.3.1 The Golgi Stress Response Pathways 
Thus far, at least five response pathways of the Golgi stress response have been revealed 
in mammalian system, namely the TFE3, CREB3, HSP47, MAPK-ETS and 
proteoglycan pathways as shown in Fig. 4. TFE3 is a key transcription factor regulating 
the TFE3 pathway. In normal growth conditions, TFE3 is phosphorylated and retained 
in the cytoplasm. Upon Golgi stress, TFE3 is dephosphorylated, translocates into the 
nucleus and activates the transcription of target genes by binding to the Golgi apparatus 
stress response element (GASE) (Taniguchi et al., 2015, 2016). The target genes of the 
TFE3 pathway include N-glycosylation enzymes, Golgi structural proteins, and 
vesicular transport components (Oku et al., 2011), suggesting that the TFE3 pathway 
augments general function of the Golgi. The sensor molecule for the TFE3 pathway has 
been yet to be discovered.  
The CREB3 pathway was identified by Reiling and colleagues (Reiling et al., 
2013), of which key transcription factor is CREB3. CREB3 is a transmembrane protein 
located in the ER membrane and functions as a sensor for Golgi stress, whereas upon 
Golgi stress CREB3 is translocated from the ER to the Golgi and is cleaved by S1P and 
S2P proteases. The cytosolic portion of cleaved CREB3 translocates to the nucleus and 
activates transcription of a small GTPase ARF4, resulting in Golgi stress-induced 
apoptosis. In addition to the CREB3 pathway, Reiling and colleagues also proposed that 
Golgi stress inducers (BFA, Golgicide A and monensin) could also evoke apoptosis via 
the mitogen activated protein kinase (MAPK)-ETS pathway (Baumann et al., 2018). 
They identified three transcription factors (ETS1, ELK1 and GAPBA/B) via 
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transcription binding motif analysis. Upon Golgi stress, these transcription factors of 
ETS family are orchestrated by MAPK to induce an apoptotic factor of MCL1, leading 
to programmed cell death. However, the details of the MAPK-ETS pathway as well as 
its relationship with the CREB3 pathway still remains obscured.  
In contrast to the CREB3 pathway, the HSP47 pathway increases the expression 
of HSP47, an ER chaperone specialized for folding and maturation of collagens, and 
suppresses Golgi stress-induced apoptosis (Miyata et al., 2013). However, the sensor, 
transcription factor, and the enhancer element of the HSP47 pathway remain to be 
identified. Recently, the proteoglycans (PGs) pathway has been revealed to increase the 
expression of PG-glycosylation enzymes upon Golgi stress (proteoglycan-type Golgi 
stress) (Sasaki et al., 2019). PGSE-A and PGSE-B are enhancer elements regulating the 
proteoglycan pathway, although the transcription factors and sensors has been 
unidentified. The proteoglycan pathway seems to be a cell type-specific response 
pathway and to be upregulated in cells producing proteoglycans including chondrocytes 
and reactive astrocytes (Sakamoto, 2017).  
 
Fig. 4. The recent studies in the mammalian Golgi stress response. At least five pathways have 
been reported, including TFE3, HSP47, CREB3, MAPK-ETS, and proteoglycan pathways 
(Sasaki and Yoshida, 2019). 
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1.3.2 Organelle Zones in the Golgi apparatus 
The functional capacity of the Golgi apparatus in its architecture is dynamic and 
flexible. As proposed by Yoshida and colleagues, various local functional regions exist 
within an organelle including the Golgi that dictates the organelle function such as the 
proteoglycan zone, the mucin zone, the GPI zone, the lipid transfer zone, and the 
degradation zone (Fig. 5) (Sasaki and Yoshida, 2019a). Since these zones are distinct 
in their function, it is believed that these zones have separate sensors, transcription 
factors, enhancer elements and target genes. This notion has prompted the analysis of 
our work to explore the existence of the mucin zone and the mucin pathway of the Golgi 
stress response that may bring a new perspective in the research of mucus 
biotherapeutics and mucus-associated diseases.  
 
 
Fig. 5. The organelle zones within the Golgi apparatus as proposed by Sasaki and Yoshida, 
2019a  
 
1.4 Analysis of the Mucin Pathway in the Mammalian Golgi Stress Response 
 
Mucus is one of the main products of goblet cells in the columnar epithelium which 
lines the surface of all important organs that are exposed to the external environment 
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(Brockhausen and Stanley, 2015). Examples include the gastrointestinal tract, the 
reproductive tract, the respiratory tract and the oculo-rhino-otolaryngeal tract. Mucus 
serves multiple functions such as lubrication and defence against foreign noxious 
stimulus (Allen et al., 1982; Birchenough et al., 2015). While serving as a barrier 
structure, it also allows the exchange of gas and nutrients, owing to its permeable feature 
from 95% water composition (Bansil and Turner, 2006).  
Mucins, the macromolecular components of mucus are heavily O-glycosylated 
proteins. They are synthesized through a series of complex glycosylation reactions in 
the Golgi apparatus which involve various types of modification enzymes (Brockhausen 
and Stanley, 2015). The glycosylation reaction of mucins initiates with the transfer of 
GalNAc from UDP-GalNAc to Ser or Thr residue of mucin core proteins, which is 
catalyzed by polypeptide N-acetyl-a-d-galactosaminyltransferases (GALNTs) that have 
more than 20 different isoforms (Hang and Bertozzi, 2005; Hanisch, 2001; Steen et al., 
1998). Attachment of the initial GalNAc triggers the action of numerous 
glycosyltransferases in a series of complex glycosylation extending the GalNAc to 
multiples diversification of different O-glycan structures (Fig. 6). 
 15 
 
Fig. 6. A series of glycosylation of mucin O-glycan in the Golgi apparatus. Glycosylation 
enzymes including GALNT5, GALNT8, and GALNT18 (in bold) were induced upon 
BenzylGalNAc treatment, which are discussed in section 3.2. 
 
 Association of mucin-type O-glycans with many diseases has been studied 
robustly, though the significance of its biological function has been still poorly 
understood. Alteration of these O-glycosylation gives rise to diverse effects in animal 
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models varying from embryonic death to developmental defects and diseases. Inhibition 
of O-glycosylation either by mutation or other factors has been known to be linked with 
various effects and diseases. For instance, mutation of GALNT3 contributes to familial 
tumoral calcinosis (Ichikawa et al., 2007; Kato et al., 2006), while malfunction of the 
glycosylating enzyme T synthase causes Tn syndrome, leading to IgA nephropathy 
(Allen et al., 2001; Hiki et al., 1999, Hiki et al., 1998). High-density lipoprotein 
metabolism impacts on coronary artery disease (Kathiresan et al., 2008; Willer et al., 
2008), and tumor generation and metastasis instigation (Kim and Varki, 1997; Ono and 
Hakomori, 2003; Springer, 1997). Furthermore, it has been implicated with altered 
immune response, resulting in decreased rolling of leukocytes due to reduced 
adhesiveness of P-selectins, E-selectins, and L-selectins lacking mucin-type 
glycosylation (Sperandio, 2006). 
 BenzylGalNAc (BG) is a classic and well-known inhibitor of mucin-type O-
glycosylation in the Golgi, and C1GALT1 is one of the key initiation enzymes in mucin-
type O-glycosylation that can be inhibited by BenzylGalNAc as shown in Fig. 7 (Huet 
et al., 1998; Kuans et al., 1989). Thus, we speculated that if mucin-producing cells are 
treated with BG, the capacity of mucin glycosylation becomes insufficient, resulting in 
accumulation of less glycosylated mucin core proteins in the Golgi (mucin-type Golgi 
stress), and that cells may activate an unknown response pathway of the Golgi stress 
response to upregulate the expression of glycosylation enzymes for mucins, namely the 
mucin pathway. In this work, we have analyzed further whether mammalian cells have 
the mucin pathway of the Golgi stress response. 
 17 
 
Fig. 7. BenzylGalNAc competitively inhibits O-glycosylation 
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 CHAPTER TWO 
     MATERIALS AND METHOD 
 
 
2.1 Cell Culture and Transfection 
 
HT29 (human colon adenocarcinoma) and HeLa cells were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) (Wako, Osaka, Japan) supplemented with 10% 
fetal bovine serum (FBS) and kept in a humidified atmosphere of 5% CO2 at 37°C 
(Yoshida et al., 2009). The calcium phosphate or PEI max methods was employed for 
transfection of  plasmid DNAs into cells, treated with 10 mM BG for 48 h, washed with 
PBS and subjected to luciferase assays, immunoblotting or immunofluorescence 
microscopy (Yoshida et al., 2006). 
 
2.2 Construction of Plasmids 
 
Corresponding regions of the human TFE3 promoter were amplified from human 
genomic DNA and cloned into the BglII site upstream of the firefly luciferase gene in a 
pGL4 basic vector (Promega, Fitchburg WI). The isolated GASE sequence from the 
human SIAT4A gene (a target gene of the TFE3 pathway) was inserted into the XhoI-
BglII sites of pGL3-promoter vector (Promega) (Oku et al., 2011). Point mutants of the 
promoter were made by site-directed mutagenesis using a QuikChange Site-Directed 
Mutagenesis kit (Stratagene, CA) (Yoshida et al., 2001). 
 
Nucleotide sequences of oligo primer pairs used for construction of corresponding 
regions of the human TFE3 promoter are listed as follows: 
 
For TFE3 promoter analysis, 
-2017 ~ +291 
Fw 5’ GGAAGATCTAGACAGGGTTTTGCCACGTT 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-1377 ~ +291 
Fw 5’ GGAAGATCTGTAGTTGGGATTACAGGCGC 3’ 
 19 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-1048 ~ +291 
Fw 5’ GGAAGATCTGCGCAACTCAGGGTGGGGTC 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-718 ~ +291 
Fw 5’ GGAAGATCTGGAGGTCCCCTTCCCTATTC 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’  
-383 ~ +291 
Fw 5’ GGAAGATCTGCCGAAAGAGGGCGCGGTTC 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-60 ~ +291 
Fw 5’ GGAAGATCTGATTGGCCGCCTCGCTAATG 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-49 ~ +291 
Fw 5’ GGAAGATCTTCGCTAATGGGTCGTGGCCA 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-37 ~ +291 
Fw 5’ GGAAGATCTCGTGGCCAGACGGGCCATCC 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-25 ~ +291 
Fw 5’ GGAAGATCTGGCCATCCATCCCCAGTGCG 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-12 ~ +291 
Fw 5’ GGAAGATCTCAGTGCGGTCACTTCCTGTG 3’ 
Rv 5’ GGAAGATCTGACGCCCGGCCCCGGGCGAG 3’ 
-12 ~ +239 
Fw 5’ GGAAGATCTCAGTGCGGTCACTTCCTGTG 3’ 
Rv 5’ GGAAGATCTCCCCTAACAAAATAAGAGTC 3’ 
-12 ~ +179 
Fw 5’ GGAAGATCTCAGTGCGGTCACTTCCTGTG 3’ 
Rv 5’ GGAAGATCTGCCATGGAGCTAGCACTGCG 3’ 
-12 ~ +119 
Fw 5’ GGAAGATCTCAGTGCGGTCACTTCCTGTG 3’ 
Rv 5’ GGAAGATCTATCCCCCGCCCAGAACGGAC 3’ 
 20 
-12 ~ +59 
Fw 5’ GGAAGATCTCAGTGCGGTCACTTCCTGTG 3’ 
Rv 5’ GGAAGATCTTCCCCCTCGTCTTCTTCCCC 3’ 
 
For TFE3 point mutation analysis, 
wt (-12 ~ +19) 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGACCGCACTGG 3’ 
-12C>A 
Fw 5’ GATCCAAGTGCGGTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGACCGCACTTG 3’ 
-11A>C 
Fw 5’ GATCCCCGTGCGGTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGACCGCACGGG 3’ 
-10G>T 
Fw 5’ GATCCCATTGCGGTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGACCGCAATGG 3’ 
-9T>G 
Fw 5’ GATCCCAGGGCGGTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGACCGCCCTGG 3’ 
-8G>T 
Fw 5’ GATCCCAGTTCGGTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGACCGAACTGG 3’ 
-7C>A 
Fw 5’ GATCCCAGTGAGGTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGACCTCACTGG 3’ 
-6G>T 
Fw 5’ GATCCCAGTGCTGTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGACAGCACTGG 3’ 
-5G>T 
Fw 5’ GATCCCAGTGCGTTCACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGAACGCACTGG 3’ 
-4T>G 
Fw 5’ GATCCCAGTGCGGGCACTTCCTGTGGAGTTTCCCCAA 3’ 
 21 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTGCCCGCACTGG 3’ 
-3C>A 
Fw 5’ GATCCCAGTGCGGTAACTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGTTACCGCACTGG 3’ 
-2A>C 
Fw 5’ GATCCCAGTGCGGTCCCTTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAAGGGACCGCACTGG 3’ 
-1C>A 
Fw 5’ GATCCCAGTGCGGTCAATTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGAATTGACCGCACTGG 3’ 
+1T>G 
Fw 5’ GATCCCAGTGCGGTCACGTCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGACGTGACCGCACTGG 3’ 
+2T>G 
Fw 5’ GATCCCAGTGCGGTCACTGCCTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGGCAGTGACCGCACTGG 3’ 
+3C>A 
Fw 5’ GATCCCAGTGCGGTCACTTACTGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACAGTAAGTGACCGCACTGG 3’ 
+4C>A 
Fw 5’ GATCCCAGTGCGGTCACTTCATGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACATGAAGTGACCGCACTGG 3’ 
+5T>G 
Fw 5’ GATCCCAGTGCGGTCACTTCCGGTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCACCGGAAGTGACCGCACTGG 3’ 
+6G>T 
Fw 5’ GATCCCAGTGCGGTCACTTCCTTTGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCAAAGGAAGTGACCGCACTGG 3’ 
+7T>G 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGGGGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCCCCAGGAAGTGACCGCACTGG 3’ 
+8G>T 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTTGAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTCAACAGGAAGTGACCGCACTGG 3’ 
 22 
+9G>T 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGTAGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACTACACAGGAAGTGACCGCACTGG 3’ 
+10A>C 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGCGTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAACGCCACAGGAAGTGACCGCACTGG 3’ 
+11G>T 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGATTTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAAAATCCACAGGAAGTGACCGCACTGG 3’ 
+12T>G 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGGTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAACCTCCACAGGAAGTGACCGCACTGG 3’ 
+13T>G 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGTGTCCCCAA 3’ 
Rv 5’ GATCTTGGGGACACTCCACAGGAAGTGACCGCACTGG 3’ 
+14T>G 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGTTGCCCCAA 3’ 
Rv 5’ GATCTTGGGGCAACTCCACAGGAAGTGACCGCACTGG 3’ 
+15C>A 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGTTTACCCAA 3’ 
Rv 5’ GATCTTGGGTAAACTCCACAGGAAGTGACCGCACTGG 3’ 
+16C>A 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGTTTCACCAA 3’ 
Rv 5’ GATCTTGGTGAAACTCCACAGGAAGTGACCGCACTGG 3’ 
+17C>A 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGTTTCCACAA 3’ 
Rv 5’ GATCTTGTGGAAACTCCACAGGAAGTGACCGCACTGG 3’ 
+18C>A 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGTTTCCCAAA 3’ 
Rv 5’ GATCTTTGGGAAACTCCACAGGAAGTGACCGCACTGG 3’ 
+19A>C  
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGAGTTTCCCCCA 3’ 
Rv 5’ GATCTGGGGGAAACTCCACAGGAAGTGACCGCACTGG 3’ 
 
 23 
 
For MGSE motif mutation analysis, 
Mutation of ‘ACTTCC’ motif 
Fw 5’ GATCTCAGTGCGGTCCAGGAATGTGGAGTTTCCCCA 3’ 
Rv 5’ TGGGGAAACTCCACATTCCTGGACCGCACTGAGATC 3’ 
Mutation of ‘TCCCCA’ motif 
Fw 5’ ACTTCCTGTGGAGTTGAAAACTCCCTGGGAGGAGGG 3’ 
Rv 5’ CCCTCCTCCCAGGGAGTTTTCAACTCCACAGGAAGT 3’ 
Mutation of both motif 
Fw 5’ GATCTCAGTGCGGTCCAGGAATGTGGAGTTGAAAAC 3’ 
Rv 5’ GTTTTCAACTCCACATTCCTGGACCGCACTGAGATC 3’ 
 
For MGSE spacer mutation, 
Fw 5’ GATCCCAGTGCGGTCACTTCCGTGTTCTGGTCCCCAA 3’ 
Rv 5’ GATCTTGGGGACCAGAACACGGAAGTGACCGCACTGG 3’ 
 
For MGSE spacer serial deletion mutation, 
3 nt deletion 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTGGATCCCCAA 3’ 
Rv 5’ GATCTTGGGGATCCACAGGAAGTGACCGCACTGG 3’ 
6 nt deletion 
Fw 5’ GATCCCAGTGCGGTCACTTCCTGTTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAACAGGAAGTGACCGCACTGG 3’ 
9 nt deletion 
Fw 5’ GATCCCAGTGCGGTCACTTCCTCCCCAA 3’ 
Rv 5’ GATCTTGGGGAGGAAGTGACCGCACTGG 3’ 
 
2.3 Quantitative RT-PCR  
 
Total RNA was isolated from HT29 cells treated with appropriate Golgi stress inducers 
(benzylGalNAc or monensin) using Sepasol-RNA I Super G (Nacalai Tesque), in 
accordance with manufacturer’s protocol. Applied Biosystems™ 7500 Real-Time PCR 
Systems (Thermo Fisher Scientific, Waltham, MA) and PrimeScript RT reagent kit with 
gDNA Eraser and SYBR Premix Ex Taq II (Tli RNase H Plus) (TaKaRa, Otsu, Japan) 
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were utilized to carry out quantitative RT-PCR (qRT-PCR) (Sasaki et al., 2019). 
Nucleotide sequences of primer pairs used here were as follows:  
 
GAPDH 
Fw 5’ GGCACAGTCAAGGCTGAGAATG 3’ 
Rv 5’ ATGGTGGTGAAGACGCCAGTA 3’ 
TFE3 
Fw 5’ ACTGGGCACTCTCATCCCTAAGTC 3’ 
Rv 5’ TTCAGGATGGTGCCCTTGTTC 3’ 
HSP47  
Fw 5’ AAGAGCAGCTGAAGATCTGGATG 3’ 
Rv 5’ GTCGGCCTTGTTCTTGTCAATG 3’ 
GALNT5,  
Fw 5’ GGCCTGTCCAGTAATCGAAGTCA 3’ 
Rv 5’ AAAGTTCATGGGCCACACAAAGA 3’ 
GALNT8 
Fw 5’ AACCATGCTCCAAGGCAGCTA 3’ 
Rv 5’ CATCTCCAGACACCGCTTGGTA 3’ 
GALNT18  
Fw 5’ TGCCTGACCTCAGACCCCAGT 3’ 
Rv 5’ TGTCATCCACCAGAATGATCTCC 3’ 
 
2.4 Luciferase Assay 
 
Transient transfection of HT29 cells was carried out as described in section 2.1. HT29 
cells cultured in 24-well plates or 96-well plates were harvested with passive lysis buffer 
(ToyoInk, Tokyo, Japan). Activities of Firefly and Renilla luciferase were measured 
with 7.5 μl of cell lysates using the PicaGene Dual Sea Pansy Luminescence Kit 
(ToyoInk, Tokyo, Japan) and measured by CentroXS LB960 luminometer (Berthold, 
Wildbad, Germany). Relative activity was defined as the ratio of firefly luciferase 
activity to Renilla luciferase activity and was calculated by simply dividing 
luminescence intensity obtained with the assay for firefly luciferase by that for Renilla 
luciferase. 
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2.5 Immunoblotting  
 
Whole cell extracts were prepared by lysing HT29 cells with 1x 40 μl sample buffer 
(sample buffer contain 20 μl of 4xSDS [200 mM Tris-Cl (pH 6.8), 400 mM DTT, 8% 
SDS, 0.4% bromophenol blue and 40% glycerol] and 20 μl of PBS:Protease 
inhibitor:Phospatase inhibitor of 100:40:1 ratio, respectively). Lysates were boiled, and 
portions (8 μl) were subjected to SDS-polyacrylamide gel electrophoresis using 10% 
gel, transferred onto a Immobilon-P transfer membrane (MilliporeSigma, USA), and 
reacted with anti-TFE3, anti-β-tubulin (primary antibody), or anti-rabbit IgG-HRP (GE 
Health care) (secondary antibody) antisera according to the standard protocol. Anti-
TFE3 antiserum was prepared in the previous study (Taniguchi et al., 2015). Prestained 
SDS-PAGE standards (Bio-rad) were used as size markers. The EZ-ECL blotting 
detection kit (Biological Industries) was used to detect each antigen.  
 
2.6 Immunocytochemistry 
 
HeLa or HT29 cells grown on cover slips were transiently transfected with an 
appropriate expression plasmid by the calcium phosphate method. Cells were fixed with 
4% paraformaldehyde/PBS for 10 min, permeabilized with 0.2% Triton X-100 for 10 
min, and stained with appropriate antibody (anti-Giantin, anti-GM 130 or anti-TFE3). 
Anti-Giantin and anti-GM130 antisera were purchased from COVANCE (Princeton, 
NJ) (#PRB-114C) and Becton Dickinson and Company (Franklin Lakes, New Jersey) 
(#610823), respectively. Anti-TFE3 antiserum was prepared in the previous study 
(Taniguchi et al., 2015). Cover slips were mounted with 5 μl SlowFade Gold Antifade 
Reagents (Life technologies) containing 0.2 ng/μl of DAPI. Images were acquired using 
a Ni-U microscope (Nikon) and ORCA-Flash4.0 V3 digital CCD camera (Hamamatsu 
Photonics).  
 
2.7 Microarray Analyses and RNA Sequencing with a Next-Generation DNA 
Sequencer 
 
Total RNA was extracted from HT29 cells treated with 10 mM BG for 48 h by the acid 
guanidium/phenol/chloroform method using Sepasol (Nacalai Tesque) and purified 
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using RNeasy Mini column (Qiagen). Microarray analyses were performed using the 
SurePrint G3 Human GE 8x60K v2 Microarray (Agilent Technologies, Santa Clara, 
CA) in collaboration with TaKaRa Bio Inc. RNA-Seq analyses were performed with 
the Ion Proton System for Next-Generation Sequencing with PI chips (Thermo Fisher 
Scientific, Waltham, MA). The microarray and RNA-seq data were deposited in GEO 
database (GEO accession numbers are GSE117938 and GSE119909, respectively).  
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 CHAPTER THREE 
     RESULTS 
 
 
3.1 Insufficiency of Mucin-Type O-glycosylation (Golgi stress) Resulted in 
Fragmentation of the Golgi apparatus 
 
Mucins are glycoproteins that receive a number of mucin-type O-glycans in the Golgi 
apparatus by specific glycosylation enzymes for mucins such as GALNTs (Jensen et 
al., 2010). Thus, it is possible that the capacity of mucin-type glycosylation becomes 
insufficient, and expression of these glycosylation enzymes should be induced by the 
mucin pathway of the Golgi stress response when cells increase expression of mucins. 
Actually, it has been reported that the Golgi apparatus becomes well developed during 
differentiation of mucin-secreting cells in the Brunner’s glands (Fig. 2B) (Berger and 
Roth, 1997). The main theme of this thesis is to reveal the molecular mechanism of the 
mucin pathway. To investigate the mucin pathway, I developed two types of the 
experimental systems in which the mucin pathway is artificially activated in culture 
cells, that is, overexpression of mucin core proteins and inhibition of mucin-type 
glycosylation by treatment of BenzylGalNAc (BG). I speculated that overexpression of 
mucin core proteins requires large number of glycosylation enzymes and this may cause 
insufficiency of glycosylation enzymes for mucins in the Golgi (mucin-type Golgi 
stress), resulting in activation of the mucin pathway. As mentioned in the literatures of 
Chapter 1.4, BG is a chemical compound that inhibits mucin-type O-glycosylation, and 
could cause insufficiency of mucin type O-glycosylation (mucin-type Golgi stress), 
resulting in activation of the mucin pathway. 
 First, I examined the effect of overexpression of mucin core proteins such as 
MUC1 and MUC20 on the morphology of the Golgi in HeLa cells. HeLa cells were 
used for this experiment instead of HT29 cells, because HeLa cells synthesize lower 
amount of mucins and the effect of overexpression of mucin core proteins in HeLa cells 
seemed greater than that in HT29 cells, which synthesize relatively large amount of 
mucins.  HeLa cells were transfected with an expression vector of MUC1 or MUC20 
(3xFLAG-MUC1 or 3xFLAG-MUC20) for 48 hours and were stained using anti-
Giantin (the cis and medial-Golgi marker) and anti-FLAG antisera for 
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immunofluorescence observation as described in “Experimental Procedures” section in 
Chapter 2.6. The Golgi apparatus in HeLa cells that were not transfected with an 
expression vector showed typical Golgi morphology (indicated by open arrow heads in 
Fig. 8A and Fig. 8B), whereas, the Golgi in HeLa cells transfected with an expression 
plasmid of 3xFLAG-MUC1 or 3xFLAG MUC20 was severely fragmented, suggesting 
that the functional capacity of Golgi was overwhelmed and leading to the fragmentation 
of Golgi (closed arrow heads in Fig. 8A and Fig. 8B).  
 Next, I examined the effect of BG on Golgi morphology. HT29 cells were 
treated with BG for 48 hours and was assessed by immunofluorescence microscopy. 
Immunofluorescence staining for the cis-Golgi marker GM130 revealed that the Golgi 
was substantially disassembled when cells were treated with BG whereas (Fig. 8C, 
panels E and F), whereas the Golgi was intact in cells treated with DMSO (panels B and 
C), suggesting that BG could be used to activate the mucin pathway.  We then repeated 
the same experiment with HeLa cells and found that the disruption of Golgi in HeLa 
cells was less severe as compared to the disruption of Golgi in HT29 cells (Fig. 8D, 
panels E and F). It is important to note that HeLa cells produce lower amount of mucin 
proteins, suggesting that the disruption of Golgi induced by BG is dependent with the 
amount of mucin production. Presumably, proteins incompletely modified with mucin-
type glycans might accumulate in the Golgi and cause disruption of Golgi morphology.  
From these observations that inhibition of glycosylation by BG and 
overexpression of mucin core protein overwhelms the Golgi functional capacity and 
induces Golgi stress, we concluded that the mucin pathway of the Golgi stress response 
does exist and mucin-type Golgi stress causes perturbation of the Golgi, leading to 
fragmentation of Golgi morphology.  
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Fig. 8 Morphological changes of the Golgi apparatus upon mucin type-Golgi stress.  
(A) HeLa cells transfected with a 3×FLAG-MUC1 expression vector were stained with anti-
FLAG (orange) and anti-Giantin (green) antisera. Bars = 50 μm. Closed and open arrow heads 
indicate cells that overexpressed or did not overexpress 3×FLAG-MUC1, respectively. (B) 
HeLa cells transfected with a 3×FLAG-MUC20 expression vector were stained with anti-FLAG 
(orange) and anti-Giantin (green) antisera. Bars = 50 μm. Closed and open arrow heads indicate 
cells that overexpressed and did not overexpress 3×FLAG-MUC20, respectively. (C) HT29 
cells treated with 10 mM BG for 48 h were stained with DAPI (blue) and anti-GM130 antibody 
(green). Bars = 10 μm. (D) The same experiment as (C) was performed using HeLa cells.  
  
A 
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3.2 Mucin-type Golgi Stress Induces the Transcription of HSP47 Gene and 
Mucin-related Genes 
 
It was previously reported that upon treatment with BG mucin-type O-
glycosylation in the Golgi is severely inhibited and the level of HSP47 mRNA was 
increased in Colo 205 and NIH3T3 cells in order to suppress Golgi stress-induced cell 
apoptosis (Miyata et al., 2013). Prompted by a previous study, we recapitulated HSP47 
mRNA induction in HT29 cells using qRT-PCR to confirm that BG can induce mucin-
type Golgi stress in HT29 cells. As shown in Fig. 9A, we found that the expression of 
HSP47 mRNA was elevated after BG treatment for 48 h (lanes 1 and 2). This finding 
indicates that BG induces Golgi stress and increases transcription of HSP47 mRNA in 
our experimental system. 
 To check whether BG treatment induces transcription of genes encoding mucin-
type glycosylation enzymes, total RNA was prepared from HT29 cells treated with BG 
for 48 h and subjected to microarray analyses (data not shown) and qRT-PCR analyses. 
Akin to the effect of BG on the level of HSP47 mRNA, we found that the expression 
levels of GALNT5, GALNT8, and GALNT18 mRNA were also upregulated upon BG 
treatment (Fig. 9B-D). These findings strongly suggested that the expression of 
enzymes for mucin-type glycosylation was augmented by mucin-type Golgi stress 
(insufficiency of mucin glycosylation) upon BG treatment. Together with the results 
from section 3.1, these observations suggest that mucin-type Golgi stress was induced 
by inhibition of mucin-type O-glycosylation and named this novel response pathway as 
the mucin pathway. 
 
3.3 Mucin-type Golgi Stress Unexpectedly Induced Transcription of Human 
TFE3 Gene 
 
Transcription factor E3 (TFE3) is a basic-helix-loop-helix domain-containing 
transcription factor that is a key transcription factor regulating the TFE3 pathway of the 
mammalian Golgi stress response (Taniguchi et al., 2015). In normally growing cells, 
TFE3 is highly phosphorylated and retained in the cytoplasm, whereas upon treatment 
with activators of the TFE3 pathway such as monensin and nigericin, TFE3 is activated 
by dephosphorylation at Ser108, although there is no upregulation of TFE3 mRNA. 
Surprisingly, we found that BG treatment increased the expression of TFE3 mRNA 
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(Fig. 9E). We then further examined whether BG can elevate the transcription of human 
TFE3 gene independently from the activation of the TFE3 pathway. When HT29 cells 
were treated with monensin (a typical inducer of the TFE3 pathway) and subjected to 
qRT-PCR, we found that expression of TFE3 mRNA was not affected by monensin 
treatment (Fig. 9F). Taken together, these results indicated that the mucin pathway 
induces TFE3 transcription independently of the TFE3 pathway, and that there is an 
interesting possibility of the existence of crosstalk from the mucin pathway to the TFE3 
pathway in the mammalian Golgi stress response, which prompted us to devote our 
investigation on the molecular mechanism of the crosstalk between these signaling 
pathways for the rest of this study.  
 
 
Fig. 9. Effect of BG on the expression of HSP47, GALNT8, GALNT5, GALNT18, and TFE3 
mRNAs. Total RNA prepared from HT29 cells treated with 10 mM BG for 48 h or  
0.3 μm monensin were subjected to qRT-PCR experiments (A, B, D, E, and F) or to RNA 
sequencing. 
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3.4 Analysis of human TFE3 Gene Promoter upon Mucin-type Golgi Stress 
 
To clarify the molecular mechanism of the crosstalk from the mucin pathway to the 
TFE3 pathway, we performed promoter analysis to investigate the effect of BG 
treatment on transcription from the promoter of the human TFE3 gene. The [-2017 to 
+291] region of the human TFE3 gene (numbers indicate the position from the 
transcription start site) and its deletion constructs indicated in the Fig. 10 were fused 
with a firefly luciferase gene and transfected into HT29 cells. HT29 cells were then 
treated with BG for 48 h before the cells were harvested for luciferase assays  
(Fig. 10). Transcriptional induction by BG treatment was evaluated by measuring the 
luciferase activity of these constructs corrected by Renilla luciferase activity which was 
used as a standard of transfection efficiency. From these experiments, we found that all 
deletion constructs shown in Fig. 10 exhibited high activity of transcriptional induction 
upon BG treatment, suggesting that the [-12 to +19] region is sufficient for 
transcriptional induction of human TFE3 gene upon mucin-type Golgi stress, and that 
the enhancer element regulating transcriptional induction resides within that region. 
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Fig. 10. Promoter analysis of the human TFE3 promoter. HT29 cells were transiently 
transfected with reporter constructs containing the indicated regions of the human TFE3 
promoter and a luciferase reporter gene, treated with 10 mM BG for 48 h, and subjected to 
luciferase assays. The estimated locations of enhancers regulating transcriptional induction are 
indicated by black boxes. The vacant reporter plasmid pGL4 basic was used as control. Values 
are means ± SE of six independent experiments. ***, P < 0.001; **, P < 0.01; *, P < 0.05. 
 
3.5 Identification of an Enhancer Element Activating Transcriptional 
Induction of the Human TFE3 Gene 
 
To determine the critical sequence of the enhancer element regulating the 
transcriptional induction of TFE3, we introduced point mutations into each nucleotide 
within the [-12 to +19] region, and the mutant promoters fused with luciferase gene 
were subjected to luciferase assays as described in Chapter 2.4 (Fig. 11). In contrast to 
the activity of transcriptional induction of a wild-type (WT) sequence (lane 2), those of 
point mutants in Region A or Region B were markedly reduced (lanes 13-18 and lanes 
28-33, respectively). These results suggested that the critical sequence of the enhancer 
element activating transcription of human TFE3 gene is ACTTCC(N9)TCCCCA. We 
named this enhancer element as the mucin-type Golgi stress response element (MGSE). 
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Fig. 11. Point mutation analysis of the [-12 to +19] region of the human TFE3 promoter. HT29 
cells were transiently transfected with luciferase reporters containing the [-12 to +19] region of 
human TFE3 promoter, treated with 10 mM BG for 48 h, and subjected to luciferase assays. 
Each single nucleotide in the [-12 to +19] region was mutated to another nucleotide (A, T, G, 
and C were replaced by C, G, T, and A, respectively). The vacant reporter plasmid pGL4 basic 
was used as vector control. Values are means ± SE of five independent experiments. 
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3.6 The MGSE is Essential for Transcriptional Induction of TFE3 upon Mucin-
type Golgi Stress 
 
From the above results, we discovered that MGSE has two motifs separated by 
9 nucleotides (nt). To reveal whether the two motifs of MGSE sequence and 9 nt of 
spacing between these two motifs is essential for transcriptional induction of the TFE3 
promoter, we strategically constructed several mutant TFE3 promoters and evaluated 
them by luciferase assay as follows (Fig. 12). First, we evaluated the importance of 
Region A and Region B motifs by mutating Region A, Region B or both (Fig. 11A). A 
vector control was barely affected by BG treatment (lane 1), whereas a reporter 
containing the WT promoter ([-12 to +292]) significantly increased luciferase activity 
upon BG treatment (lane 2). Meanwhile, mutation of “ACTTCC”, “TCCCCA” or both 
markedly reduced transcriptional induction compared to the wild type (lanes 3-5), 
implying that both motifs of MGSE are essential for activity of MGSE. Although it can 
be noted that the P-value of lane 1 in Fig. 12A has one asterisk, it appears that luciferase 
activity was too low, which leads to the fluctuation of the P-value. 
 Next, we evaluated the importance of the spacer sequence “TGTGGAGTT” that 
separates the “ACTTCC” and the “TCCCCA” motifs (Fig. 12B). We replaced the WT 
spacer sequence with “GTGTTCTGG” and measured the luciferase activity upon BG 
treatment together with the WT in lane 7 and 8. The luciferase activity of the mutated 
spacer sequence was not significantly different compared to the WT, suggesting that the 
nucleotide sequence of the spacer region itself is not essential for MGSE activity. 
 Finally, we evaluated the importance of the 9 nt distance between the 
“ACTTCC” and “TCCCCA” motifs (Fig. 12C). Mutant MGSEs containing only 6, 3, 
or 0 nt spacer sequences exhibited significantly reduced activity (lanes 11-13), 
indicating that the 9 nt distance that separates two motifs (but not the nucleotide 
sequence itself) is crucial for the activity of MGSE. These results suggested that 
ACTTCC(N9)TCCCCA is the critical sequence of MGSE and is sufficient for 
transcriptional induction of TFE3 in response to mucin-type Golgi stress. 
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Fig. 12. Contribution of MGSE to transcriptional induction of the TFE3 gene and importance 
of the spacer region of MGSE. (A) Mutation of the MGSE sequence in the [-12 to +292] region 
of the human TFE3 promoter. HT29 cells transfected with the indicated reporter plasmids were 
treated with 10 mM BG for 48 h and subjected to luciferase assays. A and B indicate the 
ACTTCC and TCCCCA motifs of MGSE, respectively. (B) Mutation of the spacer sequence 
between ACTTCC and TCCCCA motifs of MGSE. The spacer sequence of wild-type 
‘TGTGGAGTT’ was mutated to ‘GTGTTCTGG’. Activity of the mutated sequences ([-12 to 
+19]) were evaluated as described in (A). (C) Stepwise deletion mutation of the spacer 
sequence. Cells transfected with the indicated reporter plasmids were processed as described in 
(B). Reporter plasmid pGL4 basic was used as the control. Values are means ± SE of three 
independent experiments. ***, P < 0.001; **, P < 0.01; *, P < 0.05.  
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3.7 Transcription from MGSE is Activated by Overexpression of Mucin Core 
Proteins 
 
In the section 3.1, we performed two experimental approaches to activate the 
mucin pathway, either by overexpression of mucin core proteins (MUC1 or MUC20) 
or inhibition of mucin-type O-glycosylation by BG. As we have identified the MGSE 
enhancer via induction by BG treatment only, it is possible that the transcriptional 
induction from MGSE by BG treatment is not related to mucin-type Golgi stress since 
BG is a small chemical compound. Therefore, in order to confirm that MGSE is 
essential to enhance transcription of TFE3 upon mucin-type Golgi stress, we 
investigated whether MUC1 or MUC20 overexpression can induce the transcription 
from MGSE (Fig. 13). We co-transfected HT29 cells with an expression vector of 
3×FLAG-MUC1 or 3×FLAG-MUC20 as well as a 1× or 3×MGSE reporter, and 
measured relative luciferase activity. Overexpression of MUC1 or MUC20 had hardly 
affected luciferase activity of a vacant reporter (lanes 1 and 4), whereas it had 
significantly increased transcription from 1xMGSE or 3xMGSE (lanes 2, 3, 5, and 6), 
suggesting that transcription from MGSE is activated by the overexpression of mucin 
core proteins. These results strongly supported our notion that MGSE is an enhancer 
regulating transcriptional induction of TFE3 in response to mucin-type Golgi stress. 
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Fig. 13. HT29 cells transiently co-transfected with a 3×FLAG-MUC1 or 3×FLAG-MUC20 
expression plasmid and a luciferase reporter containing 1×MGSE and 3×MGSE as indicated. A 
vacant reporter plasmid pGL4 basic was used as a control. Values are means ± SE of three 
independent experiments. *, P < 0.05. 
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3.8 Mucin-type Golgi Stress Induced TFE3 Dephosphorylation and Nuclear 
Translocation but Unable to Induce GASE 
 
As mentioned in section 3.3, induction of TFE3 transcription by mucin-type 
Golgi stress has sparked an interesting possibility of existence of crosstalk by which 
mucin-type Golgi stress could activate not only the mucin pathway but also the TFE3 
pathway. In normally growing cells, TFE3 is retained in the cytoplasm as a dormant 
form through phosphorylation at Ser108. Upon activation of the TFE3 pathway, three 
main events occur; (1) dephosphorylation of TFE3 at Ser108, (2) nuclear translocation 
of TFE3 after dephosphorylation, and subsequently, (3) transcriptional induction of 
target genes of the TFE3 pathway (such as GCP60, SIAT4A and SIAT10) from an 
enhancer element GASE. Hence, we sought to examine the crosstalk mechanism by 
analyzing the activation status of the TFE3 pathway upon mucin-type Golgi stress, 
based on these three events. 
 First, we examined the phosphorylation status of TFE3 upon mucin-type Golgi 
stress by immunoblotting (Fig. 14). In line with previous report (Taniguchi et al., 2015), 
we observed eight bands of TFE3 in HT29 cells in normally growing cells as shown in 
Fig. 14A (lane 1 and lane 5), The four upper bands correspond to the large forms of 
TFE3 (TFE3(L)), and the four lower bands are derived from the short forms (TFE3(S)). 
The difference in molecular weight of each of the four bands is due to differences in 
phosphorylation status. When HT29 cells were treated with vehicle (DMSO), the 
phosphorylation status of TFE3 barely changed (lanes 2–4). On the other hand, we 
found that TFE3 was started to dephosphorylate around 4 h (lane 6) and later, more 
dephosphorylation of TFE3 was detected around 8 h after BG treatment (lanes 7 and 8), 
suggesting that mucin-type Golgi stress induces TFE3 dephosphorylation. Expression 
of TFE3 was increased 8 h after BG treatment, reflecting transcriptional induction of 
TFE3 by mucin-type Golgi stress. 
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Fig. 14. Phosphorylation status of TFE3 upon BG treatment. (A) HT29 cells treated with 10 
mM BG for the indicated time periods were subjected to immunoblotting using anti-TFE3 and 
anti-β-tubulin antisera. TFE3(L) and (S) are long and short forms of TFE3, respectively, and 
(P-) represents phosphorylated TFE3. (B) Ratio of signal detected between dephosphorylated 
TFE3 and total TFE3. Signals of TFE3(L) and (S) in (B) were quantified and plotted 
accordingly. 
  
A 
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 Second, we investigated whether TFE3 translocates into the nucleus upon BG 
treatment (Fig. 15). When endogenous TFE3 was stained with anti-TFE3-A antiserum 
in normally growing HT29 cells, TFE3 was observed in the cytoplasm (panels a–c). 
Interestingly, after BG treatment, TFE3 was localized in the nucleus (panels d–r), 
demonstrating that TFE3 rapidly translocates into the nucleus upon mucin-type Golgi 
stress. Unexpectedly, TFE3 in BG-treated cells was stained as particles in the nucleus, 
and we speculate that TFE3 may be located on the promoters of its target genes or that 
TFE3 formed liquid droplets by liquid–liquid phase separation. We then further 
examined whether overexpression of MUC1 or MUC20 causes nuclear translocation of 
TFE3, and found that TFE3 was localized in the nucleus in cells overexpressing MUC1 
or MUC20 (closed arrowhead) (Fig. 16A and Fig. 16B). On the contrary, TFE3 
remained in the cytoplasm in cells that did not overexpress 3×FLAG-MUC1 and 
3×FLAG-MUC20, respectively (open arrowhead). These results suggest that mucin-
type Golgi stress induces nuclear translocation of TFE3. 
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Fig. 15. Nuclear translocation of TFE3 upon BG treatment. HT29 cells treated with 10 mM of 
BG for the indicated times were subjected to immunocytochemistry using anti-TFE3 antiserum 
and DAPI for staining. Bars = 20 μM. 
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Fig. 16. Nuclear translocation of TFE3 upon MUC1 or MUC20 overexpression. (A) HeLa cells 
transfected with a 3×FLAG-MUC1 expression vector were stained with anti-FLAG (orange) 
and anti-TFE3 (green) antisera. Bars = 50 μm. Closed and open arrow heads indicate cells that 
overexpressed or did not overexpress 3×FLAG-MUC1, respectively. (B) HeLa cells transfected 
with a 3×FLAG-MUC20 expression vector were stained with anti-FLAG (orange) and anti-
TFE3 (green) antisera. Bars = 50 μm. Closed and open arrow heads indicate cells that 
overexpressed and did not overexpress 3×FLAG-MUC20, respectively. 
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 Third, we evaluated transcriptional induction from GASE upon mucin-type 
Golgi stress (Fig. 17). Vector control and 4xGASE mutant were used as a negative 
control for this experiment. As expected, overexpression of TFE3 increased 
transcription from GASE (lane 2, blue bar), but not from mutant GASE or vector control 
(lanes 1 and 3, blue bar). Surprisingly, BG-treated HT29 cells did not induce 
transcription from GASE, denoting that GASE cannot be activated by BG treatment 
alone. This suggests that mucin-type Golgi stress increases transcription, 
dephosphorylation, and nuclear translocation of TFE3 but it is not sufficient for 
transcriptional induction from GASE (see discussion). Although it can be noted that the 
P-value of lane 1 in Fig. 17A has one asterisk, it appears that luciferase activity was too 
low which leads to the fluctuation of the P-value 
 
 
Fig. 17. Effects of BG treatment on GASE-mediated transcriptional induction. HT29 cells were 
transiently transfected with the indicated plasmids and subjected to luciferase assays. Reporter 
plasmid pGL3pro was used as the control, and is shown in lane 1. Experiments were repeated 
five times. ***, P < 0.001; **, P < 0.01; *, P < 0.05. 
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 CHAPTER FOUR 
  DISCUSSION 
 
 
The Golgi stress response is gradually recognized as one of the organelle autoregulation 
systems. However, the molecular mechanisms how the Golgi apparatus senses the 
insufficiency of its functional capacity (Golgi stress) to instigate reestablishment of its 
organelle function has been yet to be discovered. Currently, at least five mammalian 
Golgi stress response pathways have been reported: the TFE3, HSP47, CREB3, MAPK-
ETS, and PGSE pathway. Among these pathways, Miyata et al., 2013 identified the 
HSP47 pathway of the mammalian Golgi stress response, which is important for 
suppression of apoptosis induced by Golgi stress. Interestingly, the HSP47 pathway is 
activated by BenzylGalNAc, a chemical compound that can inhibit mucin glycosylation 
enzymes in the Golgi, which leads to insufficient mucin-type glycosylation. Mucin-type 
glycosylation of proteins is one of the important function of the Golgi apparatus, 
suggesting that inhibition of mucin-type glycosylation by BG may lead to accumulation 
of improperly modified mucin core proteins, and that mucin-secreting cells have to 
augment the expression of enzymes via an unidentified pathway of the Golgi stress 
response, that is, the mucin pathway.  
 In this study, we observed that upon insufficiency of mucin-type glycosylation 
(mucin-type Golgi stress), the expression levels of GALNT5, GALNT8 and GALNT18 
were increased, thus, we named this novel pathway the mucin pathway. Strikingly, an 
unanticipated finding in the similar analysis was that incubation of cells with mucin-
type Golgi stress induced the expression of TFE3 mRNA, a transcription factor 
regulating the TFE3 pathway of the Golgi stress response, implying the existence of 
crosstalk from the mucin pathway to the TFE3 pathway. Here, through analysis of the 
human TFE3 promoter and its mutants, we have identified a novel enhancer regulating 
transcriptional induction of the TFE3 gene upon mucin-type Golgi stress which we 
named MGSE, of which the critical sequence was ACTTCC(N9)TCCCCA. 
Furthermore, we found that TFE3 is dephosphorylated and translocates into the nucleus 
upon mucin-type Golgi stress, although transcription from GASE was not affected by 
mucin-type Golgi stress. From these observations, we concluded that the mucin 
pathway generates a crosstalk signal to the TFE3 pathway. 
 47 
 Further analysis of MGSE demonstrates that the activity of MGSE is dependent 
on the distance between the ACTTCC and TCCCCA motif which indicates that the 
distance that separates these two motifs is critical. It is possible that the transcription 
factors that bind to MGSE formed a heterodimer or two distinct transcription factors 
may synergistically bind to each portion. A similar situation is reported in the case of 
the ER stress response element (ERSE; consensus sequence CCAAT(N9)CCACG), an 
enhancer regulating the ATF6 pathway of the mammalian ER stress response (Yoshida 
et al., 1998). The transcription factor NF-Y binds to the CCAAT sequence, and another 
transcription factor, ATF6, requires both the CCACG sequence and NF-Y binding to 
the CCAAT sequence for its binding. Because the distance of 9 nt almost corresponds 
to one turn of a DNA double helix, transcription factors binding to MGSE seem to 
interact each other like ATF6 and NF-Y (Yoshida et al., 2001). 
 We have been trying to identify an enhancer element that regulates 
transcriptional induction of GALNT5, GALNT8, and GALNT18 in response to mucin-
type Golgi stress, and it is still unknown whether it shares any similarity or consensus 
with MGSE. Based on our survey of database, no MGSE-like sequences can be found  
in the human GALNT5, GALNT8, and GALNT18 promoters, suggesting that the 
enhancer element is unique from MGSE. As for an enhancer element regulating the 
transcriptional induction of HSP47 after BG treatment, we reasoned that it is distinct 
from MGSE and the enhancer for GALNTs, because (1) HSP47 promoter bears no 
obvious resemblance to MGSE sequence, and (2) the HSP47 pathway regulates a quite 
distinctive response compared to the mucin pathway, which is unrelated with 
glycosylation, rather, it suppresses apoptosis upon Golgi stress.  
 In comparison with potent activators of the TFE3 pathway such as monensin, 
BG seems to have distinct mode of action because: (1) BG upregulates expression of 
the TFE3 mRNA, whereas, monensin does not affect the expression of TFE3 mRNA 
(Fig. 9F) (Taniguchi et al., 2015); and (2) monensin activates the TFE3 pathway, 
including nuclear translocation and dephosphorylation of TFE3 as well as 
transcriptional induction from GASE (Oku et al., 2011), whereas BG, however, induces 
nuclear translocation and dephosphorylation of TFE3 only (Fig. 14 and Fig. 15) but 
unable to upregulate transcriptional induction from GASE (Fig. 17). Thus, BG does not 
stimulate a sensor for the TFE3 pathway and cannot trigger full activation of TFE3 
pathway (including induction of GASE). In addition, there are two kinds of crosstalk 
signals from the mucin pathway to the TFE3 pathway, namely a signal enhancing 
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transcription of the TFE3 gene and a signal inducing dephosphorylation of TFE3 protein 
(Fig. 18). This raises the following three questions. First, why BG-treated cells did not 
activate transcription from GASE? We speculated that it is because cells have to avoid 
accidental activation of the TFE3 pathway. If the mucin pathway directly activated 
transcription from GASE, it could be induced without activation of the TFE3 pathway. 
Second, how do cells suppress ectopic transcriptional activation from GASE upon BG 
treatment? It is notable that crosstalk signals induced by BG treatment increases 
expression, dephosphorylation and nuclear translocation of TFE3, but it is not enough 
for transcriptional activation from GASE. We speculated that full activation of the TFE3 
pathway may require additional signals, possibly additional post-translational 
modifications of TFE3 protein or transcription factors other than TFE3, which are 
induced or activated by the TFE3 pathway. Third, what is the biological significance of 
these crosstalk signals? We assumed that mucin-secreting cells require very high 
general Golgi capacity such as vesicular transport and N-glycosylation, because they 
produce high numbers of mucin proteins. Thus, cells enhance the TFE3 pathway using 
these crosstalk signals during differentiation of mucin-secreting cells such as goblet 
cells. 
 In the case of the ER stress response, crosstalk exists between the IRE1 and 
ATF6 pathways. pATF6(N), a transcription factor that regulates the ATF6 pathway 
(Yamamoto et al., 2007), increases the transcription of XBP1 (Yoshida et al., 2000), 
which is a key transcription factor regulating the IRE1 pathway (Yoshida et al., 2003). 
Thus, the ATF6 pathway enhances the response of the IRE1 pathway. However, the 
ATF6 pathway only partially activates the IRE1 pathway, because ATF6 just increases 
the expression of XBP1 pre-mRNA, which has to be converted to mature mRNA by 
IRE1-mediated non-conventional mRNA splicing in order to produce an active 
transcription factor pXBP1(S) (Fig. 18) (Yoshida et al., 2001). 
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Fig. 18. Working hypothesis of crosstalk signaling from the mucin pathway to the TFE3 
pathway. Crosstalk from the ATF6 pathway to the IRE1 pathway in the ER stress response 
pathway is also indicated.   
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 Like the ER and Golgi stress responses, many studies are now progressing to 
clarify the mechanism that augments the capacity of each organelle in accordance with 
cellular demands, including the lysosomal stress response (Napolitano and Ballabio, 
2016), the mitochondrial unfolded protein response (Shpilka and Haynes, 2018), and 
the peroxisome stress response, which are collectively called organelle autoregulation 
(Sasaki and Yoshida, 2015). Elucidation of the mechanisms of organelle autoregulation 
is one of the most fundamental issues in cell biology, because they are essential for the 
autonomy of eukaryotic cells. Insufficiency of functional capacity is sensed by 
specialized sensors localized on or in each organelle, which relay signals to transcription 
factors to augment their functions. Subsequently, transcription factors bind to unique 
enhancer elements to increase the expression of organelle-specific genes. In order to 
understand the perspective of organelle autoregulation, clarification of these regulators 
is crucial. 
 
  
 51 
 CHAPTER FIVE 
     CONCLUSIONS AND FUTURE DIRECTION 
 
 
5.1 Conclusions 
 
Identification of the mucin pathway of the mammalian Golgi stress response has 
diversified the current niche of organelle autoregulation, particularly in the Golgi stress 
response. Our current analyses have shown that the perturbation of mucin O-
glycosylation or excessive number of mucin core proteins can lead to chaos and stress 
inside the Golgi apparatus. Thus, the Golgi activates the novel response pathway of the 
Golgi stress response (the mucin pathway) in order to maintain its homeostasis by 
inducing expression of glycosylation enzyme genes such as GALNT5, GALNT8, and 
GALNT18. Moreover, we identified a novel enhancer element MGSE and the 
unanticipated existence of crosstalk among mammalian Golgi stress response pathways, 
which will contribute to identifying the sensors and the transcription factors. 
Delineating the details of the mucin pathway could uncover more discovery towards 
understanding the mucus and facilitate the new development of therapeutic strategies 
for Golgi- or mucus-associated diseases. 
 
5.2 Future Direction 
 
Future works are required to identify a transcription factor(s) that enhances the TFE3 
transcription from MGSE upon mucin-type Golgi stress. We will try to isolate the 
transcription factor by adopting yeast one-hybrid screening method. In brief, tandem 
repeats of the MGSE sequence will be ligated upstream of the yeast HIS3 gene. This 
plasmid will then be integrated into HIS3-deficient yeast cells (KMY1015) together 
with human pancreas cDNA library fused with the activation domain of yeast 
transcription factor GAL4, and transfected yeast cells were incubated on growth plates 
lacking histidine. Human cDNA will be recovered from yeast cells that can grow in the 
absence of histidine in order to identify the candidates of the transcription factors 
binding to MGSE. However, if two distinct gene products are required for binding to 
MGSE, Y1H screening cannot identify the transcription factors. In that case, CRISPR-
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Cas9 screening will then be adopted, and the experiment conditions should be optimized 
for data collection and analysis.  
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